Abdulelah J. Alqahtani
Qal`at Bishah, 61922, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 26, 2025
Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 25, 2024
The Role of Pro-Inflammatory Chemokines CCL-1, 2, 4, and 5 in the Etiopathogenesis of Type 2 Diabetes Mellitus in Subjects from the Asir Region of Saudi Arabia: Correlation with Different Degrees of Obesity.
Journal: Journal of personalized medicine
Published: May 31, 2024
miRNAs dysregulation in ankylosing spondylitis: A review of implications for disease mechanisms, and diagnostic markers.
Journal: International journal of biological macromolecules
Published: January 17, 2024
Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 14, 2023
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 17, 2023
(R,R)-BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 27, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026